Gurumurthy, Channabasavaiah
- University of Nebraska Medical Center · Pharmacology (NIH department code)
From the FY2020 NIH awards this investigator leads as contact PI. The department is the award's.
FY2020 NIH rank #20,846
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2020Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2020 award categories
- Pharmacology
NIH Funding · FY2020
Linked Award Amount
$190.6K
Full award amounts, FY2020
Award Records
1
Records listing this PI
Award-Linked Rank
#20,846
By linked amount among FY2020 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2020 award records by amount
NIH award records listing Gurumurthy, Channabasavaiah as a PI. Multi-PI records show the full award amount for context.
- 5R21AI143394-02R21Contact PIDevelopment of humanized transgenic mice for HBV/HIV co-infection studiesUniversity of Nebraska Medical Center · Pharmacology (NIH department code)$190.6Kaward amount
Award organization
Organizations that administered FY2020 awards listing Gurumurthy, Channabasavaiah as a PI.
FY2020 award administered by University of Nebraska Medical Center (NE).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardUniversity of Nebraska Medical Center
- 2020$500K Cumulative Funding